Replies to post #283078 on Anavex Life Sciences Corp (AVXL)

[Jonjones325]

I think you’re right. The PDD results were technically not released yet.

Only pieces relevant to Alz were released. Still a whole slew of information to be given.

It may not be at a scientific conference either since they may want to have a Q and A session. Those events do not give the results the time it deserves. A dedicated conference call is better.

I believe the CTAD was a good teaser/appetizer for what’s to come. We know sleep was affected, so I’m assuming the actigraphy measures will be positive.

And since episodic memory encompasses many areas, the finer details should be promising as well.

bigBIO also said they wanted the December annual earnings call to be focused on the Rett results. So they are hoping to have those results before.

[nidan7500]

vg

Next week is big opportunity considering the Parkinson conference this coming week (George posted the link for the conference ..... Parkinson Conference 2020 on Nov 16th nd 17th).

Curious if this timing for any AVXL PDD results presentation is influenced by FDA discussions? In other words, will FDA expect AVXL must talk w/them first, before any kind of public data share?